P-glycoproteins in pathology: The multidrug resistance gene family in humans

Human Pathology

Volumn 21, Issue 1, 1990, Pages 34-48

  Weinstein, Ronald S ^a   Kuszak, Jerome R ^a   Kluskens, Larry F ^a   Coon, John S ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN;

ANIMAL CELL; CANCER CHEMOTHERAPY; DRUG RESISTANCE; GENE; HISTOCHEMISTRY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; ULTRASTRUCTURE;

ANIMAL; DRUG RESISTANCE; GENE EXPRESSION; GENES; GENETIC MARKERS; HUMAN; MEMBRANE GLYCOPROTEINS; NEOPLASMS; P-GLYCOPROTEIN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR MARKERS, BIOLOGICAL;

EID: 0025176784     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/0046-8177(90)90073-E     Document Type: Article

References (131)

1. Mechanism of multidrug resistance
2. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
3. Active efflux of daunorubicin and Adriamycin in sensitive and resistant sublines of P388 leukemia
4. Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines
5. Homology between P-glycoprotein and a bacterial transport protein suggests a model for multidrug resistance
6. The human mdr 3 gene encodes a novel P-glycoprotein homologue and gives rise to alternatively spliced mRNAs in liver
7. Structure and expression of the human MDR (P-glycoprotein) gene family
8. Multidrug resistance in the laboratory and clinic
9. The mdrl gene, responsible for multidrug-resistance, codes for P-glycoprotein
10. Altered surface membrane glycoproteins in vinca alkaloid-resistant human leukemic lymphoblasts
11. Isolation and genetic characterization of human KB cell lines resistant to multiple drugs
12. Characterization of a new drug-resistant human myeloma cell line that expresses P-glycoprotein
13. Multidrug resistance
14. Intrinsic drug resistance in human kidney cancer is associated with expression of a human multidrug-resistance gene
15. Measurement of multidrug-resistance messenger RNA in urogenital cancers; elevated expression in renal cell carcinoma is associated with intrinsic drug resistance
16. Expression of a multidrug resistance gene in human cancers
17. MDRI RNA levels in human renal cell carcinomas: Correlation with grade and prediction of reversal of doxorubicin resistance by quinidine in tumor explants
18. Chromosome-mediated gene transfer of multidrug resistance
19. Multidrug resistance of DNA-mediated transformants is linked to transfer of the human mdr1 gene
20. Expression of hamster P-glycoprotein and multidrug resistance in DNA-mediated transformants of mouse LTA cells
21. Genetics of multidrug resistance
22. An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene
23. Purification of the 170- to 180-kilodalton membrane glycoprotein associated with multidrug resistance: 170- to 180-kilodalton membrane glycoprotein is an ATPase
24. Mammalian multidrug resistance gene: Complete cDNA sequence indicates strong homology to bacterial transport proteins
25. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells
26. Circumvention of resistance to anthracyclines by calcium antagonists and other membrane-perturbing agents
27. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil
28. Increased accumulation of vincristine and Adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors
29. Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells
30. Expression of a full-length cDNA for the human MDR1 gene confers resistance to colchicine, doxorubisin, and vinblastine
31. Expression of a multidrug-resistance gene in human tumors and tissues
32. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues
33. Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK16
34. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites
35. Immunocytochemical localization of P170 at the plasma membrane of multidrug-resistant human cells
36. Purification of P-glycoprotein from plasma membrane vesicles of Chinese hamster ovary cell mutants with reduced colchicine permeability
37. Cellular resistance to actinomycin D in Chinese hamster cells in vitro: Cross-resistance, autoradiographic, and cytogenetic studies
38. Genetic and biochemical characterization of multidrug resistance
39. Membrane vesicles from multidrug-resistant human cancer cells contain a specific 150- to 170-kDa protein detected by photoaffinity labeling
40. Uptake and retention of daunomycin by mouse leukemic cells as factors in drug response
41. Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells
42. Reduced drug accumulation in multiple drug-resistant human KB carcinoma cell lines
43. Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and sensitive KB cells: Effects of verapamil and other drugs
44. The multi-drug transporter: Rapid modulation of efflux activity monitored in single cells by morphologic effects of vinblastine and daunomycin
45. The cell biology of multiple drug resistance
46. Multiple-drug resistance in human cancer
47. Molecular mechanisms of multidrug resistance in tumor cells
48. Mechanisms of multidrug resistance and implications for therapy
49. Reversal mechanism of multidrug resistance by verapamil: Direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/MDADM cells
50. The multidrug transporter, a double-edged sword
51. Drug resistance in multiple myeloma and non-Hodgkin's lymphoma: Detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy
52. Identification of members of the P-glycoprotein multigene family
53. Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum
54. Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rats
55. Expression of the multidrug resistant gene in hepatocarcinogenesis and regenerating rat liver
56. Multidrug resistance: P-glycoprotein and its allies—the elusive foes
57. Coinduction of MDR-1 multidrug-resistance and cytochrome P-450 genes in rat liver by xenobiotics
58. Multidrug resistance during chemical carcinogenesis: A mechanism revealed
59. The biochemistry of P-glycoprotein-mentioned multidrug resistance
60. Biosynthesis of heterogeneous forms of multidrug resistance-associated glycoproteins
61. P-glycoprotein and multidrug resistance in cancer chemotherapy
62. Phospholipid and ether linked phospholipid content alter with cellular resistance to vinblastine
63. Altered plasma membrane ultrastructure in multidrug-resistant cells
64. Freeze-fracture study of plasma membranes in wild type and daunorubicin-resistant Ehrlich ascites tumor and P388 leukemia cells
65. MDR gene family. Freeze-fracture studies of multidrug resistant KB epidermoid cells
66. The band 3 protein particle of the human red blood cell
67. The band 3-rich membrane of llama erythrocyte: Studies on cell shape and the organization of membrane proteins
68. Structural aspects of the red cell anion exhange protein
69. Use of computers in the analysis of intramembrane particles
70. Multidrug resistance: Molecular biology and clinical relevance
71. Sequence of mdr3 cDNA encoding a human P-glycoprotein
72. Localization of the human multiple drug resistance gene mdr1, to 7q21.1
73. The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues
74. A family of related ATP-binding subunits coupled to many distinct biological processes in bacteria
75. Mammalian multidrug resistance gene: Complete cDNA sequence indicates strong homology to bacterial transport proteins
76. The yeast STE6 gene encodes a homologue of the mammalian multidrug resistance P-glycoprotein
77. Efflux of chloroquine from Plasmodium falciparum: Mechanism of chloroquine resistance
78. Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum
79. A sensitive method for immunocytochemical detection of P-glycoprotein in multidrug-resistant human ovarian carcinoma cell lines
80. Cortical flow in animal cells
81. Focal adhesions: Transmembrane junctions between the extracellular matrix and the cytoskeleton
82. Focal adhesions and cell-matrix interactions
83. P-glyco-protein is targeted to adhesion plaques, retration fibers, and microspikes in drug resistant KB-V1 epidermoid carcinoma cells
84. Progesterone interacts with P-glycoprotein in multidrug-resistant cells and in the endometrium of gravid uterus
85. The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus
86. Epidermal growth factor receptor is increased in multidrug-resistance Chinese hamster and mouse tumor cells
87. Plasma membrane proteins and glycoproteins from Chinese hamster cells sensitive and resistant to actinomycin D
88. Increased synthesis of a low molecular weight protein in vincristine-resistant cells
89. Sorcin (V19), a soluble acidic calcium-binding protein overproduced in multidrug-resistant cells. Identification of the protein by antisorcin antibody
90. Purification of the Mr 22,000 calcium-binding protein (sorcin) associated with multidrug resistance and its detection with monoclonal antibodies
91. Resistance of multidrug-resistant lines to natural killer-like cell mediated cytotoxicity
92. Susceptibility of chemoresistant murine and human tumor cells to lysis by interleukin 2-activated lymphocytes
93. Evidence that multidrug resistance in Chinese hamster ovary cells is associated with alterations in the endoplasmic reticulum
94. Membrane-mediated drug resistance and phenotypic reversion to normal growth behavior of Chinese hamster cells
95. Cellular concomitants of multidrug resistance
96. Molecular mechanisms and diagnostics of multidrug resistance in human tumor cells
97. Isolation and characterization of ultramicrobacteria from a gulf coast estuary
98. Survival strategies of bacteria in the natural environment
99. The tumor dormant state. Quantitation of L5178Y cells and host immune responses during the establishment and course of dormancy in syngeneic DBA/2 mice
100. The tumor dormant state. Comparison of L5178Y cells used to establish dormancy with those that emerge after its terminaton
101. Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies
102. Immunohistochemical localization in normal tissues of different epitopes in a multidrug transport protein P170: Evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein
103. Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells revealed by monoclonal antibodies
104. Monoclonal antibody JSB-1 detects a highly conserved epitope on the P-glycoprotein associated with multi-drug-resistance
105. A monoclonal antibody-Pseudomonas toxin conjugate that specifically kills multidrug-resistant cells
106. Human multidrug-resistant cell lines: Increased mdr1 expression can precede gene amplification
107. Genetic probes in the diagnostic laboratory. Part I: Concepts and techniques
108. Detection of P-glycoprotein in ovarian cancer: A molecular marker associated with multidrug resistance
109. P-glycoprotein in human sarcoma: Evidence for multidrug resistance
110. Detection of a multidrug resistant phenotype in acute non-lymphoblastic leukaemia
111. Increased P-glycoprotein expression and multidrug-resistant gene (mdr1) amplification are infrequently found in fresh acute leukemia cells. Sequential analysis of 15 cases of initial presentation and relapsed stage
112. Multidrug resistance in haemopoietic cell lines, myelodysplastic syndromes and acute myeloblastic leukaemia
113. Immunohistochemical detection and quantitation of P-glycoprotein in multiple drug-resistant human myeloma cells: Association with level of drug resistance and drug accumulation
114. Treatment of refractory multiple myeloma and considerations for future therapy
115. Optical microscope system for standardizing cell measurements and analysis
116. Gene amplification and drug resistance in cultured murine cells
117. Different mechanisms of multiple drug resistance in two human leukemia cell lines
118. Expression of a human multidrug resistance gene in ovarian carcinomas
119. Multidrug resistance in mitoxantrone-selected HL-60 leukemia cells in the absence of P-glycoprotein overexpression
120. Direct correlation between topoisomerase II activity and cytotoxicity in Adriamycin-sensitive and resistant P388 leukemia cell lines
121. Altered DNA topoisomerase II activity in Chinese hamster cells resistant to topoisomerase Ii inhibitors
122. Contribution of drug transport and reductases to daunorubicin resistance in human myelocytic cells
123. Intracellular distribution and pharmokinetics of daunorubicin in anthracycline-sensitive and -resistant HL-60 cells
124. Multidrug resistance
125. Verapamil reversal of clinical doxorubicin resistance in human cancer
126. Verapamil and Adriamycin in the treatment of drug-resistant ovarian cancer patients
127. Clinical modulation of doxorubicin resistance by the calmodulin-inhibitor, trifluoperazine: A phase 1/11 trial
128. Clinical trial of continuous infusion verapamil, bolus vinblastine, and continuous infusion VP-16 in drug-resistant pediatric tumors